Personalized Search
Displaying 161 - 180 of 1079
Key Points
Itacitinib monotherapy is as effective as systemic corticosteroids for the treatment of low risk acute GVHD.
Itacitinib monotherapy resulted in fewer serious infections compared to systemic corticosteroids.
The standard primary treatment for acute graft vs host disease (GVHD) requires prolonged, high dose systemic corticosteroids (SCS) that delay reconstitution of the immune system.…
Article last updated
.
Node ID (debugging only): 1501
Dr. Jacqueline Garcia discusses the use of hypomenthylating agents.
Podcast Episode last updated
.
Node ID (debugging only): 1253
What is "Chemo Brain" and how is it managed? Find out the best approaches for dealing with this common side effect in this recording with Dr. Jorg Dietrich.
Podcast Episode last updated
.
Node ID (debugging only): 1265
Dr. Bhumika Patel explains why meningitis can occur in patients with PNH and how it is both treated or prevented.
Podcast Episode last updated
.
Node ID (debugging only): 1264
Dr. Rory Shallis discusses a variety of current treatments for MDS, or
Myelodysplastic Syndromes
Myelodysplastic Syndromes:
(my-eh-lo-diss-PLASS-tik SIN-dromez) A group of disorders where the bone marrow does not work well, and the bone marrow cells fail to make enough healthy blood cells. Myelo refers to the bone marrow. Dysplastic means abnormal growth or development. People…
Podcast Episode last updated
.
Node ID (debugging only): 1254
When should patients be vaccinated, and with which version of the COVID-19 Vaccine? Learn all about how each type of vaccine works and which patients with
bone marrow failure
bone marrow failure:
A condition that occurs when the bone marrow stops making enough healthy blood cells. The most common of these rare diseases are aplastic anemia, myelodysplastic syndromes (MDS) and…
Podcast Episode last updated
.
Node ID (debugging only): 1263
What does the diagnosis, Intermediate-Risk MDS mean? Learn from
Myelodysplastic Syndromes
Myelodysplastic Syndromes:
(my-eh-lo-diss-PLASS-tik SIN-dromez) A group of disorders where the bone marrow does not work well, and the bone marrow cells fail to make enough healthy blood cells. Myelo refers to the bone marrow. Dysplastic means abnormal growth or development. People with MDS have…
Podcast Episode last updated
.
Node ID (debugging only): 1260
Key Points
In MDS, health-related quality of life (HRQoL) was worse for vulnerable participants and those with worse prognosis.
Lower-risk MDS was associated with better HRQoL, but this relationship was lost among the vulnerable.
Health-related quality of life (HRQoL) and vulnerability are variably affected in patients with
myelodysplastic syndromes
myelodysplastic syndromes:
(my-eh-…
Article last updated
.
Node ID (debugging only): 1504
What is a
clinical trial
clinical trial:
A type of research study that tests how a drug, medical device, or treatment approach works in people. There are several types of clinical trials. Treatment trials test new treatment options. Diagnostic trials test new ways to diagnose a disease. Screening trials test the best way to detect a…
? Why should a patient consider participating…
Podcast Episode last updated
.
Node ID (debugging only): 1262
Christina Cline, RN, at the University of Florida Health Cancer Center, describes one of the common symptoms of treatment for
bone marrow failure
bone marrow failure:
A condition that occurs when the bone marrow stops making enough healthy blood cells. The most common of these rare diseases are aplastic anemia, myelodysplastic syndromes (MDS) and paroxysmal nocturnal hemoglobinuria (PNH…
Podcast Episode last updated
.
Node ID (debugging only): 1261
Dr. Joshua Zeidner explains why it is critical for patients to receive an accurate diagnosis for MDS, or
Myelodysplastic Syndromes
Myelodysplastic Syndromes:
(my-eh-lo-diss-PLASS-tik SIN-dromez) A group of disorders where the bone marrow does not work well, and the bone marrow cells fail to make enough healthy blood cells. Myelo refers to the bone marrow. Dysplastic means abnormal…
Podcast Episode last updated
.
Node ID (debugging only): 1259
Dr. Norkin explains why and how patients with PNH can develop blood clots, as well as prevention and treatment.
Podcast Episode last updated
.
Node ID (debugging only): 1258
Dr. Timothy Pardee discusses treatments for AML, or
Acute Myeloid Leukemia
Acute Myeloid Leukemia:
(uh-KYOOT my-uh-LOYD loo-KEE-mee-uh) A cancer of the blood cells. It happens when very young white blood cells (blasts) in the bone marrow fail to mature. The blast cells stay in the bone marrow and become to numerous. This slows production of red blood cells and platelets. Some cases of…
Podcast Episode last updated
.
Node ID (debugging only): 1257
Dr. Nandita Khera discusses why and when transplants can be recommended for older patients in this podcast episode.
Podcast Episode last updated
.
Node ID (debugging only): 1255
Dr. Allyson Pishko shares the latest advances in the treatment of PNH, or
Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria:
(par-uk-SIZ-muhl nok-TURN-uhl hee-muh-gloe-buh-NYOOR-ee-uh) A rare and serious blood disease that causes red blood cells to break apart. Paroxysmal means sudden and irregular. Nocturnal means at night. Hemoglobinuria means hemoglobin in…
Podcast Episode last updated
.
Node ID (debugging only): 1256
Dr Vu Duong explains risk classifications for MDS. He dives into IPSS and IPSS-R scores, focused on helping patients to understand the meanings of high-risk and low-risk MDS.
Podcast Episode last updated
.
Node ID (debugging only): 1246
Kat hears patients ask: "I have this
bone marrow failure
bone marrow failure:
A condition that occurs when the bone marrow stops making enough healthy blood cells. The most common of these rare diseases are aplastic anemia, myelodysplastic syndromes (MDS) and paroxysmal nocturnal hemoglobinuria (PNH). Bone marrow failure can be acquired (begin any time in life) or can be…
problem ...…
Podcast Episode last updated
.
Node ID (debugging only): 1233
The recently-approved hypomethylating treatment, Inoqvi, is a daily oral version of two IV or subcutaneous medications. Listen to Dr. Amer Zeidan of Yale Cancer Center explain which MDS patients could qualify, and what it means for their treatment at the link.
Podcast Episode last updated
.
Node ID (debugging only): 1252
From a sunny, lively retirement to MDS then AML? That was Shirley's life! After treatment in a
Clinical Trial
Clinical Trial:
A type of research study that tests how a drug, medical device, or treatment approach works in people. There are several types of clinical trials. Treatment trials test new treatment options. Diagnostic trials test new ways to diagnose a disease. Screening…
Podcast Episode last updated
.
Node ID (debugging only): 1232
Dr. Eunice Wang explains the origin and treatment of
secondary MDS
secondary MDS:
A type of MDS that is caused by a previous treatment foranother another disorder or disease. Treatments typically associated with secondary MDS include radiation therapy and chemotherapy used to treat cancer. Also called therapy-related MDS, T-MDS.
. Dr. Wang is the Chief of the Leukemia Service at Roswell…
Podcast Episode last updated
.
Node ID (debugging only): 1251